These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17624800)

  • 41. A novel antibody-4-1BBL fusion protein for targeted costimulation in cancer immunotherapy.
    Müller D; Frey K; Kontermann RE
    J Immunother; 2008 Oct; 31(8):714-22. PubMed ID: 18779748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody.
    Ménez R; Michel S; Muller BH; Bossus M; Ducancel F; Jolivet-Reynaud C; Stura EA
    J Mol Biol; 2008 Feb; 376(4):1021-33. PubMed ID: 18187150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure of IL-17A in complex with a potent, fully human neutralizing antibody.
    Gerhardt S; Abbott WM; Hargreaves D; Pauptit RA; Davies RA; Needham MR; Langham C; Barker W; Aziz A; Snow MJ; Dawson S; Welsh F; Wilkinson T; Vaugan T; Beste G; Bishop S; Popovic B; Rees G; Sleeman M; Tuske SJ; Coales SJ; Hamuro Y; Russell C
    J Mol Biol; 2009 Dec; 394(5):905-21. PubMed ID: 19835883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dealing with intractable protein cores: protein sequencing of the Mcg IgG and the Yvo IgM heavy chain variable domains.
    Shaw DC; Shultz BB; Ramsland PA; Edmundson AB
    J Mol Recognit; 2002; 15(5):341-8. PubMed ID: 12447912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Energy-based analysis and prediction of the orientation between light- and heavy-chain antibody variable domains.
    Narayanan A; Sellers BD; Jacobson MP
    J Mol Biol; 2009 May; 388(5):941-53. PubMed ID: 19324053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding activity difference of anti-CD20 scFv-Fc fusion protein derived from variable domain exchange.
    Geng SS; Feng J; Li Y; Sun Y; Gu X; Huang Y; Wang Y; Kang X; Chang H; Shen B
    Cell Mol Immunol; 2006 Dec; 3(6):439-43. PubMed ID: 17257497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains.
    Kim YJ; Neelamegam R; Heo MA; Edwardraja S; Paik HJ; Lee SG
    J Microbiol Biotechnol; 2008 Jun; 18(6):1186-90. PubMed ID: 18600066
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chicken IgY binds its receptor at the CH3/CH4 interface similarly as the human IgA: Fc alpha RI interaction.
    Pürzel J; Schmitt R; Viertlboeck BC; Göbel TW
    J Immunol; 2009 Oct; 183(7):4554-9. PubMed ID: 19748988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
    Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
    J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analyzing the "degree of humanness" of antibody sequences.
    Abhinandan KR; Martin AC
    J Mol Biol; 2007 Jun; 369(3):852-62. PubMed ID: 17442342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystal structure of chimeric antibody C2H7 Fab in complex with a CD20 peptide.
    Du J; Wang H; Zhong C; Peng B; Zhang M; Li B; Hou S; Guo Y; Ding J
    Mol Immunol; 2008 May; 45(10):2861-8. PubMed ID: 18346788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A therapeutic Trojan horse: intracellular antibodies].
    Teillaud JL
    Pathol Biol (Paris); 1999 Oct; 47(8):771-5. PubMed ID: 10573694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crystal structure of an anti-ganglioside antibody, and modelling of the functional mimicry of its NeuGc-GM3 antigen by an anti-idiotypic antibody.
    Talavera A; Eriksson A; Okvist M; López-Requena A; Fernández-Marrero Y; Pérez R; Moreno E; Krengel U
    Mol Immunol; 2009 Oct; 46(16):3466-75. PubMed ID: 19748674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Humanization of high affinity anti-HBs antibody by using human consensus sequence and modification of selected minimal positional template and packing residues.
    Tiwari A; Khanna N; Acharya SK; Sinha S
    Vaccine; 2009 Apr; 27(17):2356-66. PubMed ID: 19428851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure and mechanism of a transmission blocking vaccine candidate protein Pfs25 from P. falciparum: a molecular modeling and docking study.
    Sharma B
    In Silico Biol; 2008; 8(3-4):193-206. PubMed ID: 19032156
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains.
    Honegger A; Malebranche AD; Röthlisberger D; Plückthun A
    Protein Eng Des Sel; 2009 Mar; 22(3):121-34. PubMed ID: 19136675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IMGT, the international ImMunoGeneTics information system, http://imgt.cines.fr.
    Lefranc MP
    Novartis Found Symp; 2003; 254():126-36; discussion 136-42, 216-22, 250-2. PubMed ID: 14712935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structure and dynamics of the anti-AMCV scFv(F8): effects of selected mutations on the antigen combining site.
    Arcangeli C; Cantale C; Galeffi P; Rosato V
    J Struct Biol; 2008 Oct; 164(1):119-33. PubMed ID: 18662789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.